发明名称 Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors
摘要 This invention provides compositions and methods for treating and vaccinating against an Her2/neu antigen-expressing tumor and inducing an immune response against dominant and several sub-dominant epitopes of the antigen.
申请公布号 US9084747(B2) 申请公布日期 2015.07.21
申请号 US201012945386 申请日期 2010.11.12
申请人 Advaxis, Inc.;The Trustees Of The University Of Pennsylvania 发明人 Shahabi Vafa;Wallecha Anu;Maciag Paulo C.;Paterson Yvonne;Seavey Matthew
分类号 A61K39/02;C12N15/52;C07K14/00;A61K39/00 主分类号 A61K39/02
代理机构 Pearl Cohen Zedek Latzer Baratz LLP 代理人 Cohen Mark S.;Pearl Cohen Zedek Latzer Baratz LLP
主权项 1. A recombinant Listeria strain having mutations in the D-alanine racemase (Dal) gene and the D-amino acid transferase (Dat) gene, said recombinant Listeria strain comprising a nucleic acid encoding a first and a second open reading frame, wherein said first open reading frame encodes a recombinant polypeptide comprising SEQ ID NO: 2 fused to a) non-hemolytic LLO protein or N-terminal fragment, b) a PEST sequence, or c) an ActA fragment, and wherein said second open reading frame encodes a metabolic enzyme that complements said mutations, and wherein said recombinant Listeria lacks the ActA virulence gene.
地址 Princeton NJ US